National Health Investors, Inc. / Fundamentals

    Income statement

    Net revenue
    €299.77M
    Cost of goods sold
    €36.44M
    Gross profit
    €263.33M
    SG&A expenses
    €21.67M
    R&D expenses
    €0.00
    EBITDA
    €234.72M
    D&A
    €65.42M
    EBIT
    €161.62M
    Interest expenses
    €35.56M
    EBT
    €121.40M
    Tax expenses
    €0.00
    Net income
    €122.64M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€10.02M
    Changes in working capital
    €1.84M
    Operating cash flow
    €182.32M
    Capex
    €2.18M
    Other investing cash flow
    -€243.68M
    Net investing cash flow
    -€245.87M
    Total cash dividends paid
    -€138.57M
    Issuance of common stock
    €0.00
    Debt repayment
    €109.29M
    Other financing cash flow
    €194.33M
    Net financing cash flow
    €65.62M
    Foreign exchange effects
    €0.00
    Net change in cash
    €2.08M
    Cash at end of period
    €16.58M
    Free cash flow
    €184.51M

    Balance sheet

    Cash and cash equivalents
    €15.99M
    Cash and short-term investments
    €15.99M
    Total receivables
    €76.45M
    Inventory
    €0.00
    Other current assets
    €0.00
    Total current assets
    €92.44M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €2.31B
    Accounts payable
    €0.00
    Short-term debt
    €0.00
    Other current liabilities
    €0.00
    Total current liabilities
    €3.48M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €1.02B
    Total non-current liabilities
    €1.02B
    Total liabilities
    €1.03B
    Common stock
    €0.00
    Retained earnings
    €2.30B
    Other equity
    €0.00
    Total equity
    €1.28B
    Total liabilities and shareholders' equity
    €2.30B

    Company information

    Market capitalization
    €2.82B
    Employees
    30
    Enterprise Value
    €4.46B

    Company ratios

    Gross margin
    87.8% Even with peer group: 84.9%
    EBITDA margin
    78.3% Better than peer group: 67.4%
    EBIT margin
    53.9% Better than peer group: 42.2%
    EBT margin
    40.5% Better than peer group: 23.1%
    Net margin
    40.9% Better than peer group: 29.2%
    ROE
    9.6% Worse than peer group: 22.2%
    ROA
    5.3% Even with peer group: 1.9%
    Asset turnover
    13.0% Worse than peer group: 24.3%
    FCF margin
    60.1% Much better than peer group: 7.5%
    FCF yield
    6.4%
    Efficiency ratio
    21.7%
    Net sales per employee
    €9.99M
    Net income per employee
    €4.09M

    Notifications